Cargando…

Prostate Cancer Radiation Therapy: What Do Clinicians Have to Know?

Radiotherapy (RT) for prostate cancer (PC) has steadily evolved over the last decades, with improving biochemical disease-free survival. Recently population based research also revealed an association between overall survival and doses ≥ 75.6 Gray (Gy) in men with intermediate- and high-risk PC. Exa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vanneste, Ben G. L., Van Limbergen, Evert J., van Lin, Emile N., van Roermund, Joep G. H., Lambin, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5225325/ https://www.ncbi.nlm.nih.gov/pubmed/28116302 http://dx.doi.org/10.1155/2016/6829875

Ejemplares similares

A biodegradable rectal balloon implant to protect the rectum during prostate cancer radiotherapy for a patient with active Crohn’s disease
por: Vanneste, Ben G.L., et al.
Publicado: (2018)

Chronic radiation proctitis: tricks to prevent and treat
por: Vanneste, Ben G. L., et al.
Publicado: (2015)

Is prostate cancer radiotherapy using implantable rectum spacers safe and effective in inflammatory bowel disease patients?
por: Vanneste, Ben G.L., et al.
Publicado: (2021)

Radiation for Oligometastatic Lung Cancer in the Era of Immunotherapy: What Do We (Need to) Know?
por: Peeters, Stephanie T. H., et al.
Publicado: (2021)

Development and validation of a patient decision aid for prostate Cancer therapy: from paternalistic towards participative shared decision making
por: Ankolekar, Anshu, et al.
Publicado: (2019)

Evaluation of hyaluronic acid gel dissolution with hyaluronidase in an in-vitro prostate cancer model
por: Vanneste, Ben G.L., et al.
Publicado: (2022)

Focal salvage high-dose-rate brachytherapy with implantable rectum spacer for locally recurrent prostate cancer after initial low-dose-rate with grade 3 rectal toxicity
por: Opbroek, Thirza, et al.
Publicado: (2023)

Decision Support Systems in Prostate Cancer Treatment: An Overview
por: van Wijk, Y., et al.
Publicado: (2019)

Mental health among clinicians: what do we know and what can we do?
por: Patel, Mittal, et al.
Publicado: (2021)

Maturity-Onset Diabetes of the Young: What Do Clinicians Need to Know?
por: Kim, Sung-Hoon
Publicado: (2015)

Dynamics of rectal balloon implant shrinkage in prostate VMAT: Influence on anorectal dose and late rectal complication risk
por: Vanneste, Ben G. L., et al.
Publicado: (2017)

Apheresis: What Should a Clinician Know?
por: Parhofer, Klaus G.
Publicado: (2023)

An overview of the published and running randomized phase 3 clinical results of radiotherapy in combination with immunotherapy
por: Vanneste, Ben G. L., et al.
Publicado: (2021)

Returning the student to school after concussion: what do clinicians need to know?
por: Rose, Sean C, et al.
Publicado: (2015)

What We Do and Do Not Know about Teaching Medical Image Interpretation
por: Kok, Ellen M., et al.
Publicado: (2017)

Apes have culture but may not know that they do
por: Gruber, Thibaud, et al.
Publicado: (2015)

Artificial intelligence in telemetry: what clinicians should know
por: Maslove, David M., et al.
Publicado: (2021)

What do clinicians and clinical researchers need to know about psychosocial and neurocognitive constructs?
por: Huijbregts, Stephan
Publicado: (2020)

The postictal state — What do we know?
por: Pottkämper, Julia C. M., et al.
Publicado: (2020)

Biosimilars in rheumatology: what the clinician should know
por: Castañeda-Hernández, Gilberto, et al.
Publicado: (2015)

Chyluria: what does the clinician need to know?
por: Stainer, Victoria, et al.
Publicado: (2020)

Genetics of ADHD: What Should the Clinician Know?
por: Grimm, Oliver, et al.
Publicado: (2020)

COVID-19: What do we know?
por: Marshall, Steve, et al.
Publicado: (2020)

Depression and suicide: What an evidence‐based clinician should know
por: Emmelkamp, Paul M. G., et al.
Publicado: (2022)

Quasicrystals: What do we know? What do we want to know? What can we know?
por: Steurer, Walter
Publicado: (2018)

How Similar Are Biosimilars? What Do Clinicians Need to Know About Biosimilar and Follow-On Insulins?
por: Triplitt, Curtis, et al.
Publicado: (2017)

Presbyopia: What We Do Know and What We Do Not Know in 2022
por: Grzybowski, Andrzej, et al.
Publicado: (2023)

Transmission of Ebola Viruses: What We Know and What We Do Not Know
por: Osterholm, Michael T., et al.
Publicado: (2015)

Infectious Scleritis: What the ID Clinician Should Know
por: Guerrero-Wooley, Richelle L, et al.
Publicado: (2018)

Gene Expression Profiles – What the Clinician Needs to Know
por: Gall-Troselj, Koraljka
Publicado: (2005)

Children in Coronaviruses’ Wonderland: What Clinicians Need to Know
por: Lassandro, Giuseppe, et al.
Publicado: (2020)

Biosimilar Insulins – What a Clinician Needs to Know?
por: Ghosh, Sujoy, et al.
Publicado: (2019)

Congenital Disorders of Glycosylation: What Clinicians Need to Know?
por: Lipiński, Patryk, et al.
Publicado: (2021)

Urate Transporters in the Kidney: What Clinicians Need to Know
por: Chung, Sungjin, et al.
Publicado: (2021)

Machine learning in medicine: what clinicians should know
por: Sim, Jordan Zheng Ting, et al.
Publicado: (2021)

Radioembolization for hepatocellular carcinoma: what clinicians need to know
por: Choi, Jin Woo, et al.
Publicado: (2022)

Eyes and the heart: what a clinician should know
por: Ng, Jing Yong, et al.
Publicado: (2023)

What do we know and when do we know it?
por: Nicholls, Anthony
Publicado: (2008)

Towards a Clinical Decision Support System for External Beam Radiation Oncology Prostate Cancer Patients: Proton vs. Photon Radiotherapy? A Radiobiological Study of Robustness and Stability
por: Walsh, Seán, et al.
Publicado: (2018)

Geriatric Radiation Oncology: What We Know and What Can We Do Better?
por: Roeder, Falk, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9bvs1bhodlc2isu2ol0ekf7sqj